Fund Companies Rights Offerings Managed Distributions Leveraged Funds IPOs Asset Classes CEF Advisors

My Fund Comparison
Initilizing list...


Tekla on Healthcare & Biotech:

Growing Champions, Dynamic Innovators

CEFA's Quarterly Insights features Tekla Capital Management's President and Chief Executive Officer, Dr. Daniel Omstead and Senior Vice President of Research, Jason Akus, as they examine the opportunities and outlook in the Healthcare and Biotech sectors.

Featuring:

Daniel Omstead, President & CEO Tekla Capital ManagementDan Omstead
President & Chief Executive Officer

Tekla Company Logo

Jason Akus, Senior Vice President of Research at TeklaJason Akus
Senior Vice President, Research

Nuveen Company Logo

Please fill out the form below to access the webinar replay.

The views and opinions expressed in the replay are for informational and educational purposes only as of the date of production/writing and may change without notice at any time based on factors such as market conditions or legal and regulatory developments. This material may contain “forward-looking” information that is not purely historical in nature. Such information may include, among other things, projections, forecasts, estimates of market returns, and proposed or expected portfolio composition. Past performance is no guarantee of future results. Investing involves risk; principal loss is possible. This material is not intended to be a recommendation or investment advice, does not constitute a solicitation to buy, sell or hold a security or an investment strategy, and is not provided in a fiduciary capacity. Shares of closed-end funds are subject to investment risks, including the possible loss of principal invested. Closed-end funds frequently trade at a discount to their net asset value (NAV).

 

Resources

Aberdeen Closed-End TV

Asset TV — CEF Channel

CEF Connect

Cohen & Steers CEFs Knowledge Center

Harvest — CEFA Channel

Legg Mason CEFs

Seeking Alpha — CEFA Channel


SySys Logo

Lipper Logo
Powered by a SySys data & content management system.

©Thomson Reuters 2017. All rights reserved. Any copying, republication or redistribution of Lipper, a Thomson Reuters company, content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper, a Thomson Reuters company. Lipper, a Thomson Reuters company shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.